{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T10:38:07Z","timestamp":1777891087280,"version":"3.51.4"},"reference-count":105,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Med Insights Pediatr"],"published-print":{"date-parts":[[2014,1]]},"abstract":"<jats:p>Children with autism have a high rate of irritability and aggressive symptoms. Irritability or self-injurious behavior can result in significant harm to those affected, as well as to marked distress for their families. This paper provides a literature review regarding the efficacy and tolerability of pharmacotherapy for the treatment of irritability in autistic children. Although antipsychotics have not yet been approved for the treatment of autistic children by many countries, they are often used to reduce symptoms of behavioral problems, including irritability, aggression, hyperactivity, and panic. However, among antipsychotics, the Food and Drug Administration has approved only risperidone and aripiprazole to treat irritability in autism. Among atypical antipsychotics, olanzapine and quetiapine are limited in their use for autism spectrum disorders in children because of high incidences of weight gain and sedation. In comparison, aripiprazole and ziprasidone cause less weight gain and sedation. However, potential QTc interval prolongation with ziprasidone has been reported. Contrary to ziprasidone, no changes were evident in the QT interval in any of the trials for aripiprazole. However, head-to-head comparison studies are needed to support that aripiprazole may be a promising drug that can be used to treat irritability in autistic children. On the other hand, risperidone has the greatest amount of evidence supporting it, including randomized controlled trials; thus, its efficacy and tolerability has been established in comparison with other agents. Further studies with risperidone as a control drug are needed.<\/jats:p>","DOI":"10.4137\/cmped.s8304","type":"journal-article","created":{"date-parts":[[2014,5,25]],"date-time":"2014-05-25T16:59:04Z","timestamp":1401037144000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy and Tolerability of Pharmacotherapy Options for the Treatment of Irritability in Autistic Children"],"prefix":"10.4137","volume":"8","author":[{"given":"Eiji","family":"Kirino","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Juntendo University School of Medicine, Tokyo, Japan."},{"name":"Department of Psychiatry, Juntendo University Shizuoka Hospital, Shizuoka, Japan."},{"name":"Juntendo Institute of Mental Health, Saitama Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2014,5,25]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-010-0091-8"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1H527"},{"key":"e_1_3_1_4_2","volume-title":"Interventions for Adolescents and Young Adults with Autism Spectrum Disorders.","author":"Lounds Taylor J.","year":"2012","unstructured":"Lounds TaylorJ., DoveD., Veenstra-VanderWeeleJ. AHRQ comparative effectiveness reviews. In: Interventions for Adolescents and Young Adults with Autism Spectrum Disorders. Rockville, MD: Agency for Healthcare Research and Quality (US); 2012."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2008.06.007"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ebch.1903"},{"issue":"2","key":"e_1_3_1_7_2","first-page":"130","article-title":"Review of the pharmacotherapy of irritability of autism.","volume":"21","author":"Elbe D.","year":"2012","unstructured":"ElbeD., LalaniZ. Review of the pharmacotherapy of irritability of autism. J Can Acad Child Adolesc Psychiatry. 2012; 21(2): 130\u201346.","journal-title":"J Can Acad Child Adolesc Psychiatry."},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-006-0147-5"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020593922901"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/CHI.0b013e3181b76658"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-3782"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2007.0041"},{"key":"e_1_3_1_13_2","first-page":"417","volume-title":"Understanding Autism: From Basic Neuroscience to Treatment.","author":"McDougle C.J.","year":"2006","unstructured":"McDougleC.J., PoseyD.J., StiglerK.A. Pharmacological treatments. In: MoldinS.O., RubensteinJ.L.R., editors. Understanding Autism: From Basic Neuroscience to Treatment. Boca Raton, FL: CRC Press; 2006: 417\u201342."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chc.2008.06.002"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14236-5"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.2217\/phe.10.45"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(02)00647-8"},{"key":"e_1_3_1_18_2","volume-title":"Principles and Practice of Psychopharmacotherapy.","author":"Janciak P.G.","year":"2001","unstructured":"JanciakP.G., MarderS.R., PavuluriM.N. Principles and Practice of Psychopharmacotherapy. Philadelphia, PA: Lippincott Williams & Wilkins; 2001."},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.2165\/00148581-200709040-00006"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200212000-00025"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890060309"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-7610.1987.tb00677.x"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/088307380401900301.155"},{"issue":"3","key":"e_1_3_1_24_2","first-page":"464","article-title":"The research and development of aripiprazole and its mechanism of action.","volume":"10","author":"Kikuchi T.","year":"2007","unstructured":"KikuchiT. The research and development of aripiprazole and its mechanism of action. Japanese Journal of Clinical Psychopharmacology. 2007; 10(3): 464\u20138.","journal-title":"Japanese Journal of Clinical Psychopharmacology."},{"issue":"19","key":"e_1_3_1_25_2","first-page":"6","article-title":"The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.","volume":"64","author":"Stahl S.M.","year":"2003","unstructured":"StahlS.M., ShayeganD.K. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. J Clin Psychiatry. 2003; 64 Suppl 19: 6\u201312.","journal-title":"J Clin Psychiatry."},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1101"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1201"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200923050-00002"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200401000-00003"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/026988110401800308"},{"key":"e_1_3_1_31_2","unstructured":"FindlingR.L. BlumerJ.L. KauffmanR. Pharmacokinetic effects of aripiprazole in children and adolescents with conduct disorder. Paper presented at: the XXIVth Collegium Internationale Neuro-Psychopharmacologicum Congress; June 20\u20134 2004; Paris France."},{"issue":"3","key":"e_1_3_1_32_2","first-page":"250","article-title":"Focus on aripiprazole: a review of its use in child and adolescent psychiatry.","volume":"18","author":"Greenaway M.","year":"2009","unstructured":"GreenawayM., ElbeD. Focus on aripiprazole: a review of its use in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry. 2009; 18(3): 250\u201360.","journal-title":"J Can Acad Child Adolesc Psychiatry."},{"key":"e_1_3_1_33_2","unstructured":"Otsuka Pharmaceutial Co. Abilify\u00ae prescribing information. Available from: http:\/\/www.otsuka-us.com\/Documents\/Abilify.PI.pdf Accessed May 3 2014."},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.2165\/11208280-000000000-00000"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.2165\/11207230-000000000-00000"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2008.0111"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.2165\/00148581-200709050-00006"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200822030-00006"},{"key":"e_1_3_1_39_2","unstructured":"Janssen Pharmaceuticals Inc. Risperdal\u00ae (risperidone): US prescribing information. 2011. Available from: http:\/\/www.janssenpharmaceuticalsinc.com\/assets\/risperdal.pdf Accessed December 15 2013."},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200519050-00005"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200016060-00005"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245606"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0887-8994(94)90174-0"},{"key":"e_1_3_1_44_2","first-page":"13","article-title":"The pharmacokinetics of risperidone in humans: a summary.","volume":"55","author":"Heykants J.","year":"1994","unstructured":"HeykantsJ., HuangM.L., MannensG. The pharmacokinetics of risperidone in humans: a summary. J Clin Psychiatry. 1994; 55 Suppl: 13\u20137.","journal-title":"J Clin Psychiatry."},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(94)00129-N"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245605"},{"issue":"4","key":"e_1_3_1_47_2","first-page":"602","article-title":"Dopamine receptor pharmacology.","volume":"6","author":"Seeman P.","year":"1993","unstructured":"SeemanP., Van TolH.H. Dopamine receptor pharmacology. Curr Opin Neurol Neurosurg 1993; 6(4): 602\u20138.","journal-title":"Curr Opin Neurol Neurosurg"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050551"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-199404000-00011"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246146"},{"key":"e_1_3_1_51_2","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000293665"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1192\/S0007125000293653"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.13m08500"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013171"},{"key":"e_1_3_1_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-006-0234-7"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2003-0264-F"},{"key":"e_1_3_1_57_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.7.1361"},{"key":"e_1_3_1_58_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.162.6.1142"},{"key":"e_1_3_1_59_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.16.541"},{"key":"e_1_3_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-7138(09)60969-9"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.141.10.1195"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02211843"},{"key":"e_1_3_1_63_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-198901000-00016"},{"key":"e_1_3_1_64_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199706000-00022"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200108000-00012"},{"issue":"3","key":"e_1_3_1_66_2","first-page":"77","article-title":"A double-blind, placebo-controlled study of the efficacy of transdermal Clonidine in autism.","volume":"53","author":"Fankhauser M.P.","year":"1992","unstructured":"FankhauserM.P., KarumanchiV.C., GermanM.L., YatesA., KarumanchiS.D. A double-blind, placebo-controlled study of the efficacy of transdermal Clonidine in autism. J Clin Psychiatry. 1992; 53(3): 77\u201382.","journal-title":"J Clin Psychiatry."},{"key":"e_1_3_1_67_2","doi-asserted-by":"publisher","DOI":"10.1097\/DBP.0b013e3181739b9d"},{"key":"e_1_3_1_68_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1010799115457"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000224787.13782.0f"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02179289"},{"key":"e_1_3_1_71_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005548619694"},{"key":"e_1_3_1_72_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200106000-00010"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.881792"},{"key":"e_1_3_1_74_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2008.07061035"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05164yel"},{"key":"e_1_3_1_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2011.03.019"},{"key":"e_1_3_1_77_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1791"},{"key":"e_1_3_1_78_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.0126"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2004.tb00030.x"},{"key":"e_1_3_1_80_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1549"},{"key":"e_1_3_1_81_2","doi-asserted-by":"publisher","DOI":"10.1089\/104454601317261564"},{"key":"e_1_3_1_82_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.5.918"},{"key":"e_1_3_1_83_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.6.1125"},{"key":"e_1_3_1_84_2","doi-asserted-by":"publisher","DOI":"10.1159\/000141508"},{"key":"e_1_3_1_85_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199809000-00006"},{"key":"e_1_3_1_86_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200210000-00003"},{"key":"e_1_3_1_87_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200108000-00009"},{"key":"e_1_3_1_88_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199902000-00008"},{"key":"e_1_3_1_89_2","doi-asserted-by":"publisher","DOI":"10.1080\/10673220802075852"},{"key":"e_1_3_1_90_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-007-0620-5"},{"key":"e_1_3_1_91_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199210000-00005"},{"key":"e_1_3_1_92_2","doi-asserted-by":"publisher","DOI":"10.1089\/1044546041649084"},{"key":"e_1_3_1_93_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.02.023"},{"key":"e_1_3_1_94_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2009.0120"},{"key":"e_1_3_1_95_2","doi-asserted-by":"crossref","first-page":"004","DOI":"10.4172\/2165-7890.S1-004","article-title":"Aripiprazole in patients with autistic spectrum disorders: a review and case reports.","volume":"1","author":"Kirino E.","year":"2012","unstructured":"KirinoE. Aripiprazole in patients with autistic spectrum disorders: a review and case reports. Autism \u2013 Open Access. 2012; S1: 004.","journal-title":"Autism \u2013 Open Access."},{"key":"e_1_3_1_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-012-0270-0"},{"key":"e_1_3_1_97_2","doi-asserted-by":"publisher","DOI":"10.1002\/ddrr.118"},{"key":"e_1_3_1_98_2","doi-asserted-by":"publisher","DOI":"10.1007\/s007020050152"},{"key":"e_1_3_1_99_2","doi-asserted-by":"publisher","DOI":"10.1684\/epd.2009.0238"},{"key":"e_1_3_1_100_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1115"},{"key":"e_1_3_1_101_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.1999.9.99"},{"key":"e_1_3_1_102_2","doi-asserted-by":"publisher","DOI":"10.1089\/1044546041649129"},{"key":"e_1_3_1_103_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881106067765"},{"key":"e_1_3_1_104_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2004.14.455"},{"key":"e_1_3_1_105_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200208000-00010"},{"key":"e_1_3_1_106_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0119"}],"container-title":["Clinical Medicine Insights: Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4137\/CMPed.S8304","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.4137\/CMPed.S8304","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.4137\/CMPed.S8304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:53:47Z","timestamp":1777614827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.4137\/CMPed.S8304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":105,"alternative-id":["10.4137\/CMPed.S8304"],"URL":"https:\/\/doi.org\/10.4137\/cmped.s8304","relation":{},"ISSN":["1179-5565","1179-5565"],"issn-type":[{"value":"1179-5565","type":"print"},{"value":"1179-5565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1]]},"article-number":"CMPed.S8304"}}